579
Views
62
CrossRef citations to date
0
Altmetric
Research Article

New nanomicelle curcumin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment

, , , &
Pages 1846-1857 | Received 22 Mar 2017, Accepted 21 Jun 2017, Published online: 11 Jul 2017

References

  • Guo C, Cui F, Li M, et al. Enhanced corneal permeation of coumarin-6 using nanoliposomes containing dipotassium glycyrrhizinate: in vitro mechanism/in vivo permeation evaluation. RSC Adv. 2015;5:75636–75647.
  • Bucolo C, Drago F, Salomone S. Ocular drug delivery: a clue from nanotechnology. Front Pharmacol. 2012;3:188.
  • Prosperi-Porta G, Kedzior S, Muirhead B, et al. Phenylboronic-acid-based polymeric micelles for mucoadhesive anterior segment ocular drug delivery. Biomacromolecules. 2016;17:1449–1457.
  • Joseph RR, Venkatraman SS. Drug delivery to the eye: what benefits do nanocarriers offer? Nanomedicine (Lond). 2017;12:683–702.
  • Vaishya RD, Khurana V, Patel S, et al. Controlled ocular drug delivery with nanomicelles. WIREs Nanomed Nanobiotechnol. 2014;6:422–437.
  • Nabavi SF, Thiagarajan R, Rastrelli L, et al. Curcumin: a natural product for diabetes and its complications. CTMC. 2015;15:2445–2455.
  • Lou J, Hu W, Tian R, et al. Optimization and evaluation of a thermoresponsive ophthalmic in situ gel containing curcumin-loaded albumin nanoparticles. Int J Nanomed. 2014;9:2517–2525.
  • Xie P, Zhang W, Yuan S, et al. Suppression of experimental choroidal neovascularization by curcumin in mice. PLoS One. 2012;7:e53329.
  • Pradhan N, Guha R, Chowdhury S, et al. Curcumin nanoparticles inhibit corneal neovascularization. J Mol Med. 2015;93:1095–1106.
  • Joshi RP, Negi G, Kumar A, et al. SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: an insight into its mechanism for neuroprotection. Nanomedicine. 2013;9:776–785.
  • Liu R, Sun L, Fang S, et al. Thermosensitive in situ nanogel as ophthalmic delivery system of curcumin: development, characterization, in vitro permeation and in vivo pharmacokinetic studies. Pharm Dev Technol. 2016;21:576–582.
  • Vadlapudi AD, Cholkar K, Vadlapatla RK, et al. Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility. J Ocul Pharmacol Ther. 2014;30:49–58.
  • Vaishya RD, Khurana V, Patel S, et al. Controlled ocular drug delivery with nanomicelles. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014;6:422–437.
  • Cholkar K, Gilger BC, Mitra AK. Topical delivery of aqueous micellar resolvin E1 analog (RX-10045). Int J Pharm. 2016;498:326–334.
  • Cabral H, Kataoka K. Progress of drug-loaded polymeric micelles into clinical studies. J Control Release. 2014;190:465–476.
  • Simoes SM, Figueiras AR, Veiga F, et al. Polymeric micelles for oral drug administration enabling locoregional and systemic treatments. Expert Opin Drug Deliv. 2015;12:297–318.
  • Alvarez-Rivera F, Fernandez-Villanueva D, Concheiro A, et al. α-lipoic acid in Soluplus(®) polymeric nanomicelles for ocular treatment of diabetes-associated corneal diseases. J Pharm Sci. 2016;105:2855–2863.
  • Guo C, Zhang Y, Yang Z, et al. Nanomicelle formulation for topical delivery of cyclosporine A into the cornea: in vitro mechanism and in vivo permeation evaluation. Sci Rep. 2015;5:12968.
  • Di Tommaso C, Torriglia A, Furrer P, et al. Ocular biocompatibility of novel Cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers. Int J Pharm. 2011;416:515–524.
  • Leung MH, Kee TW. Effective stabilization of curcumin by association to plasma proteins: human serum albumin and fibrinogen. Langmuir. 2009;25:5773–5777.
  • Yang R, Zhang S, Kong D, et al. Biodegradable polymer-curcumin conjugate micelles enhance the loading and delivery of low-potency curcumin. Pharm Res. 2012;29:3512–3525.
  • Harada T, Pham DT, Lincoln SF, et al. The capture and stabilization of curcumin using hydrophobically modified polyacrylate aggregates and hydrogels. J Phys Chem B. 2014;118:9515–9523.
  • Tonnesen HH. Solubility, chemical and photochemical stability of curcumin in surfactant solutions. Studies of curcumin and curcuminoids, XXVIII. Die Pharmazie. 2002;57:820–824.
  • Jahanshiri Z, Shams-Ghahfarokhi M, Allameh A, et al. Effect of curcumin on aspergillus parasiticus growth and expression of major genes involved in the early and late stages of aflatoxin biosynthesis. Iran J Public Health. 2012;41:72–79.
  • Ge W, Li D, Chen M, et al. Characterization and antioxidant activity of β-carotene loaded chitosan-graft-poly(lactide) nanomicelles. Carbohydr Polym. 2015;117:169–176.
  • Wu XG, Xin M, Chen H, et al. Novel mucoadhesive polysaccharide isolated from Bletilla striata improves the intraocular penetration and efficacy of levofloxacin in the topical treatment of experimental bacterial keratitis. J Pharm Pharmacol. 2010;62:1152–1157.
  • Xie M, Fan D, Zhao Z, et al. Nano-curcumin prepared via supercritical: Improved anti-bacterial, anti-oxidant and anti-cancer efficacy. Int J Pharm. 2015;496:732–740.
  • Dey S, Patel J, Anand BS, et al. Molecular evidence and functional expression of P-glycoprotein (MDR1) in human and rabbit cornea and corneal epithelial cell lines. Invest Ophthalmol Vis Sci. 2003;44:2909–2918.
  • Alvarado HL, Abrego G, Garduno-Ramirez ML, et al. Design and optimization of oleanolic/ursolic acid-loaded nanoplatforms for ocular anti-inflammatory applications. Nanomedicine. 2015;11:521–530.
  • Bucolo C, Maltese A, Puglisi G, et al. Enhanced ocular anti-inflammatory activity of ibuprofen carried by an Eudragit RS100 nanoparticle suspension. Ophthalmic Res. 2002;34:319–323.
  • Duan Y, Cai X, Du H, et al. Novel in situ gel systems based on P123/TPGS mixed micelles and gellan gum for ophthalmic delivery of curcumin. Colloids Surfaces. 2015;128:322–330.
  • Gupta SS, Parikh T, Meena AK, et al. Effect of carbamazepine on viscoelastic properties and hot melt extrudability of Soluplus (R). Int J Pharm. 2015;478:232–239.
  • Parikh T, Gupta SS, Meena AK, et al. Application of film-casting technique to investigate drug-polymer miscibility in solid dispersion and hot-melt extrudate. J Pharm Sci. 2015;104:2142–2152.
  • Andrade F, das Neves J, Gener P, et al. Biological assessment of self-assembled polymeric micelles for pulmonary administration of insulin. Nanomedicine. 2015;11:1621–1631.
  • Jin X, Zhou B, Xue L, et al. Soluplus((R)) micelles as a potential drug delivery system for reversal of resistant tumor. Biomed Pharmacother. 2015;69:388–395.
  • Xia D, Yu H, Tao J, et al. Supersaturated polymeric micelles for oral cyclosporine a delivery: The role of Soluplus-sodium dodecyl sulfate complex. Colloids Surf B Biointerf. 2016;141:301–310.
  • Yu H, Xia D, Zhu Q, et al. Supersaturated polymeric micelles for oral cyclosporine a delivery. Eur J Pharm Biopharm. 2013;85:1325–1336.
  • Kabanov AV, Alakhov VY. Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug Carrier Syst. 2002;19:1–72.
  • Yu H, Huang Q. Enhanced in vitro anti-cancer activity of curcumin encapsulated in hydrophobically modified starch. Food Chem. 2010;119:669–674.
  • Ghosh S, Kuchlyan J, Banik D, et al. Organic additive, 5-methylsalicylic acid induces spontaneous structural transformation of aqueous pluronic triblock copolymer solution: a spectroscopic investigation of interaction of curcumin with pluronic micellar and vesicular aggregates. J Phys Chem B. 2014;118:11437–11448.
  • Chen FP, Li BS, Tang CH. Nanocomplexation between curcumin and soy protein isolate: influence on curcumin stability/bioaccessibility and in vitro protein digestibility. J Agric Food Chem. 2015;63:3559–3569.
  • Korhonen E, Ronkko S, Hillebrand S, et al. Cytotoxicity assessment of porous silicon microparticles for ocular drug delivery. Eur J Pharm Biopharm. 2016;100:1–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.